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Capicua deﬁciency induces autoimmunity and
promotes follicular helper T cell differentiation
via derepression of ETV5
Sungjun Park1,*, Seungwon Lee2,*, Choong-Gu Lee3,*, Guk Yeol Park1, Hyebeen Hong1, Jeon-Soo Lee1,
Young Min Kim1, Sung Bae Lee4, Daehee Hwang5, Youn Soo Choi6,7, John D. Fryer8, Sin-Hyeog Im1,2,3,
Seung-Woo Lee1,2 & Yoontae Lee1,2
High-afﬁnity antibody production through the germinal centre (GC) response is a pivotal
process in adaptive immunity. Abnormal development of follicular helper T (TFH) cells can
induce the GC response to self-antigens, subsequently leading to autoimmunity. Here we
show the transcriptional repressor Capicua/CIC maintains peripheral immune tolerance by
suppressing aberrant activation of adaptive immunity. CIC deﬁciency induces excessive
development of TFH cells and GC responses in a T-cell-intrinsic manner. ETV5 expression is
derepressed in Cic null TFH cells and knockdown of Etv5 suppresses the enhanced TFH cell
differentiation in Cic-deﬁcient CD4þ Tcells, suggesting that Etv5 is a critical CIC target gene
in TFH cell differentiation. Furthermore, we identify Maf as a downstream target of the
CIC–ETV5 axis in this process. These data demonstrate that CIC maintains T-cell
homeostasis and negatively regulates TFH cell development and autoimmunity.
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T
he germinal centre (GC) response is one of the most
elegant processes in adaptive immunity and produce
antibodies that have high afﬁnity to antigens. In follicles,
B cells that recognize antigens proliferate and form GCs. GCs are
expanded by the proliferation of GC B cells and polarize into two
microenvironments, the dark zone and the light zone1–3. GC B
cells cycle between these two zones. In the dark zone, GC B cells
rapidly proliferate and undergo somatic hypermutation, which
enables antibody diversiﬁcation and afﬁnity maturation. In the
light zone, GC B cells are selected on the basis of antigen
afﬁnity, undergo immunoglobulin class-switch recombination,
and eventually give rise to antibody-secreting plasma cells or
memory B cells1–3. During the GC response, several types of
immune cell collaborate with B cells in the follicles, where
follicular helper T (TFH) cells have an instrumental function. TFH
cells facilitate the selection and maturation of high-afﬁnity GC B
cells by multiple rounds of cognate interaction with B cells in the
light zone; these interactions provide the selected B cells with
crucial signals for survival and re-entry into the dark zone3.
Because TFH cells have an important function in the generation of
isotype-switched and afﬁnity-maturated antibodies, dysregulation
of TFH cell development and function is closely associated with
immunodeﬁciency-related pathogenesis or antibody-mediated
autoimmune diseases including systemic lupus erythematosus4–6.
Differentiation of TFH cells is initiated by the interaction of
naı¨ve T cells with dendritic cells (DCs), which, together with
environmental factors, including cytokines, triggers expression of
the chemokine receptor CXCR5 on DC-primed T cells7,8. The
surface expression of CXCR5 enables T cells to migrate into B-cell
follicles7,8. T cells that are targeted to enter B-cell follicles
upregulate expression of the transcriptional repressor BCL6 and
express an intermediate level of typical TFH molecules (for
example, CXCR5, PD-1, ICOS and SAP) at the junction between
T-cell and B-cell zone9,10. At this stage, developing TFH cells
interact with cognate B cells and differentiate into GC TFH cells
that express high levels of TFH molecules, such as PD-1 and
CXCR5 (ref. 9). BCL6 as a master transcription factor for TFH cell
differentiation11–13 and BLIMP1 as an antagonist of BCL6
(ref. 11), plus several other transcription factors, help
orchestrate TFH cell differentiation by exerting either a positive
or negative effect, depending on the cellular context8. Among
these factors, MAF (also known as c-MAF) was identiﬁed as a
positive regulator of TFH cell differentiation in mice and humans.
Maf deﬁciency decreases the frequency of CD4þCXCR5þ T cells
in mice14. MAF regulates expression of Il21 in mouse TFH cells
and, in conjunction with BCL6, MAF induces expression of
CXCR4, CXCR5, PD-1, ICOS and IL-21 in human TFH cells14–16.
Moreover, MAF expression is induced in CD4þ T cells by ICOS
co-stimulation14 or by IL-6, an important cytokine for initiating
TFH cell differentiation15.
Capicua/CIC is a transcriptional repressor that is evolutionarily
conserved from cnidarians to mammals17, and it exists in short
(CIC-S) and long (CIC-L) isoforms17. In mammals, CIC interacts
with Ataxin-1/ATXN1 (ref. 18), of which polyglutamine (polyQ)-
expanded form causes spinocerebellar ataxia type-1 (SCA1)
neuropathogenesis, and its haploinsufﬁciency alleviates SCA1
progression19. Loss of the ATXN1–CIC complex results in
hyperactivity, impaired learning and memory, and abnormal
maturation and maintenance of upper-layer cortical neurons in
mice20. CIC also suppresses the progression of several types of
cancer21–23. CIC target genes that are critical for regulation
of cancer progression include PEA3 group genes, ETV1/ER81,
ETV4/PEA3 and ETV5/ERM, which are frequently overexpressed
and promote tumourigenesis and metastasis in various types of
cancer cell21,24–26. In vivo functions of CIC have been reported in
studies of Cic hypomorphic (Cic-L / ) mice19. These mice die
within 4 weeks after birth and have defects in lung
alveolarization27 and bile acid homeostasis28. However, CIC is
expressed in most mouse tissues27,28, so it may also have other
important physiological functions. CIC levels are relatively high
in the thymus27,28 and in immune cells including T and NK cells
(http://www.humanproteomemap.org)29. Moreover, our previous
study shows that genes associated with immune activation
and autoimmune diseases, such as SLE, asthma and thyroiditis,
are signiﬁcantly upregulated in the liver of Cic-L / mice28.
These ﬁndings suggest that CIC may regulate immune responses
and immune disorders.
Here we investigate CIC functions in immune system using
various immune cell-speciﬁc Cic null mice. Our study ﬁnds
previously unrecognised functions of CIC in regulation of T-cell
activation and GC responses and suggests CIC as a key
transcription factor in the suppression of autoimmunity.
Results
Autoimmunity in immune cell-speciﬁc Cic null mice. To
investigate in vivo requirement of CIC in homeostasis
and functions of immune cells, we generated haematopoietic
lineage cell-speciﬁc Cic null mice (Cicf/fVav1-Cre) by crossing
mice carrying ﬂoxed Cic alleles (Cicf/f) with Vav1-Cre mice
(Supplementary Fig. 1a), and characterized them at 9–12 weeks
of age. Development of lymphocytes in primary lymphoid
organs was largely normal (Supplementary Fig. 1b,c), although an
increase in proportion of thymic CD4þFOXP3þ regulatory
T (Treg) cells was observed (Supplementary Fig. 2).
Strikingly, all Cicf/fVav1-Cre mice developed enlarged
secondary lymphoid organs, including spleens (Fig. 1a), mainly
due to proliferation of B220þ B cells (Fig. 1b). In addition, the
number of CD8þ T cells was signiﬁcantly decreased, whereas
that of macrophages and DCs was increased in spleen of
Cicf/fVav1-Cre mice (Fig. 1b). The expression levels of several
T-cell co-stimulatory ligands, such as CD80, CD86, CD40
and ICOSL, on the surface of DCs were comparable between
Cicf/f (WT) and Cicf/fVav1-Cre mice (Supplementary Fig. 3).
Cicf/fVav1-Cre mice had a higher frequency of effector/memory-
phenotype (CD44hiCD62Llo) cells for both CD4þ and CD8þ
subsets, compared with wild-type (WT) mice (Fig. 1c).
Cic-deﬁcient CD4þCD44þ T cells showed elevated expression
of cell surface co-stimulatory molecules such as ICOS, PD-1,
OX40 and GITR (Supplementary Fig. 4). Flow cytometry analysis
on cytokine expression proﬁles revealed that the frequency
of IFNgþ , TNFþ , IL-21þ , IL-13þ and IL-22þ CD4þ T cells
was signiﬁcantly increased in spleen of Cicf/fVav1-Cre mice
(Supplementary Fig. 5a). Cicf/fVav1-Cre mice also had a higher
frequency of CCR4CXCR3þ (TH1-related) and CCR4þ
CCR6 (TH2-related) CD4þ T cells30 (Supplementary Fig. 5b).
Thus, loss of CIC spontaneously activates T cells, resulting in
accumulation of effector/memory cells with mixed T helper (TH)
phenotypes in mice. On the other hand, Cic null naı¨ve CD4þ
T cells differentiated into each TH subset with similar efﬁciency to
WT cells under in vitro polarizing conditions (Supplementary
Fig. 6), suggesting that CIC might not be a crucial factor for each
TH subset differentiation.
Cicf/fVav1-Cre mice had a higher proportion of CD4þCD25
FOXP3þ T cells in spleen, but a comparable proportion of
CD4þCD25þFOXP3þ T cells, compared with WT mice
(Supplementary Fig. 7a). Expression levels of surface molecules
that are critical for controlling Treg cell homeostasis and function,
such as GITR, CTLA-4, CD103 and GARP (refs 31,32), were
comparable between WT and Cic null CD4þ FOXP3þ T cells
regardless of CD25 expression (Supplementary Fig. 7b).
Consistent with this result, WT and Cic-deﬁcient CD4þCD25þ
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Figure 1 | Lymphoproliferative autoimmunity in immune cell-speciﬁc Cic null mice. (a,b) Spleen weights (a) and the numbers of total splenocytes,
B220þ B, CD3þ T, CD4þ T, CD8þ T, macrophages (CD11bþCD11cF4/80þ ) and dendritic cells (CD11bþCD11cþMHCIIþ ) (b) in 10-week-old Cicf/f
(WT) and Cicf/fVav1-Cre (cKO) mice. (c) FACS analysis showing the proportion of CD44loCD62Lhi naı¨ve T cells and CD44hiCD62Llo effector/memory
Tcells in spleen of Cicf/f and Cicf/fVav1-Cre mice. All data are representative of two independent experiments. Data are presented as box-and-whisker plots.
n¼4–5 per each genotype. (d) Serum levels of total IgG, IgG1, IgG2a and IgM in 12-week-old Cicf/f and Cicf/fVav1-Cre mice were measured by ELISA.
(e) Images of dissected spleens (SPL) and draining lymph nodes (LN) from Cicf/f and Cicf/fVav1-Cremice at the age of 12 months. The graph shows average
weights of spleens from the Cicf/f and Cicf/fVav1-Cre mice. M, male; F, female. (f) Serum levels of anti-dsDNA antibody in the 12-month-old Cicf/f and
Cicf/fVav1-Cre mice were measured by ELISA. The graphs in a,b,d–f show data as mean±s.e.m. and each dot in graphs represents an individual mouse.
*Po0.05, **Po0.01 and ***Po0.001 (two-tailed two-sample unequal variance Student t-test). (g) Immune cell inﬁltration in liver and lung from the
12-month-old Cicf/fVav1-Cre mice. Tissue sections were stained with haematoxylin and eosin (H&E). Arrows indicate immune cell inﬁltrates.
(h) H&E-stained kidney sections showing glomerulonephritis in the 12-month-old Cicf/fVav1-Cre mice. (i) Immunostaining for IgG deposition in kidney
glomeruli of the 12-month-old Cicf/fVav1-Cre mice. Representative images from two independent experiments are shown. (g–i) Scale bars, 100mm.
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Treg cells had a comparable suppressive activity on IL-2 secretion
and proliferation of responding CD4þCD25 T cells
(Supplementary Fig. 7c,d). The numbers of CD8þCD25þ
FOXP3þ and CD8þ ICOSLþCXCR5þ (Qa-1-restricted CD8þ
Treg cells)33,34 T cells were also comparable between WT and
Cicf/fVav1-Cre mice (Supplementary Fig. 7e,f). These results,
together with the increased frequency of thymic Treg cells
(Supplementary Fig. 2), indicate that the T cell hyperactivation
in Cicf/fVav1-Cre mice was not due to defects in Treg cell
compartment.
Because the abnormal activation of T cells and the increased
frequency of CD4þCD25FOXP3þ T cells are often associated
with autoimmunity35,36, we assessed whether Cicf/fVav1-Cre mice
display autoimmune phenotypes with age. The Cicf/fVav1-Cre
mice developed hyperglobulinemia at 12 weeks of age (Fig. 1d),
and exhibited several typical autoimmune attributes at around
1 year of age, including enlarged secondary lymphoid
organs (Fig. 1e), increased serum levels of anti-dsDNA antibody
(Fig. 1f), inﬁltration of immune cells into tissues (Fig. 1g),
glomerulonephritis (Fig. 1h) and IgG deposition in kidney
glomeruli (Fig. 1i). Together, these ﬁndings demonstrate that
CIC is indispensable for suppression of lymphoproliferative
autoimmunity.
Spontaneous induction of GC responses by CIC deﬁciency.
Increased frequencies of TFH-like cells are often observed in
patients with autoimmune diseases including SLE6, and studies of
Roquinsan mice show that overexpression of IFNg and ICOS,
a co-stimulatory molecule highly expressed in TFH cells37,38,
promotes TFH cell development, which in turn spontaneously
induces a lupus-like autoimmune syndrome39,40. It is also known
that IL-21 and IL-4 are key cytokines that TFH cells express
during the GC response41. Because Cicf/fVav1-Cre mice had the
increased T-cell surface expression of ICOS, the increased
proportions of CD4þ IFNgþ , CD4þ IL-21þ and CD4þ IL-4þ
T cells, and the autoimmune-like symptoms similar to those in
Roquinsan mice42, we set out to determine whether the TFH subset
was elevated in Cicf/fVav1-Cre mice. The frequencies of TFH
(PD-1intCXCR5int) and GC TFH (PD-1hiCXCR5hi) cells were
signiﬁcantly increased in the spleen of 9-week-old Cicf/fVav1-Cre
mice at the expense of non-TFH cells (Fig. 2a). The increased TFH
cell frequency in Cicf/fVav1-Cre mice was conﬁrmed by ﬂow
cytometry analysis of CD4þBCL6þCXCR5þ T cells (Fig. 2b).
Consistent with these results, the proportion of CD4þ ICOSþ
T cells was also markedly increased (Fig. 2c). On the other hand,
levels of BCL6 in PD-1þCXCR5þ TFH cells were comparable
between WT and Cicf/fVav1-Cre mice (Fig. 2d). The frequency of
IFNgþ TFH cells was substantially increased in Cicf/fVav1-Cre
mice, whereas that of IL-21þ and IL-4þ TFH cells was
comparable between WT and Cicf/fVav1-Cre mice (Fig. 2e).
Because the primary function of TFH cells is to help B cells form
GC reactions, we further analysed GC B (B220þFasþGL-7þ )
cells. The proportion of GC B cells was signiﬁcantly higher in
Cicf/fVav1-Cre mice than in WT mice (Fig. 2f). Taken together,
these data indicate that CIC is required for suppression of
spontaneous induction of GC reactions.
T-cell-intrinsic functions of CIC. Because several abnormalities
in T cells were observed in Cicf/fVav1-Cre mice, we next exam-
ined CIC in T cells. CIC protein levels gradually increased along
with the activation of CD4þ T cells by anti-CD3 and anti-CD28
antibodies (Fig. 3a), and were higher in effector/memory
CD4þ T cells than in naı¨ve CD4þ T cells (Fig. 3b). Cic-deﬁcient
CD4þ T cells secreted IL-2 and proliferated more efﬁciently than
WT T cells when stimulated with anti-CD3 (Fig. 3c,d), suggesting
that CIC negatively regulates an activation signal that is mediated
by T-cell receptors (TCRs). However, this difference was largely
abrogated by addition of anti-CD28 (Fig. 3c,d), indicating that
a strong co-stimulatory signal through CD28 overrides the
enhanced TCR response in Cic-deﬁcient T cells.
To determine the in vivo consequences of CIC deﬁciency in
T cells, we generated mice with Cic deletion speciﬁc to T cells
(Cicf/fCd4-Cre) (Fig. 4a). Development of T cells in thymus was
largely normal in Cicf/fCd4-Cre mice (Supplementary Fig. 8a).
Given that CIC deﬁciency induced autoimmunity and that Cic
null CD4þ T cells more robustly responded to TCR stimulation
than WT cells in vitro (Fig. 3c,d), we assessed thymic negative
selection, which is a critical process that removes autoreactive
T cells in thymus43, in WT and Cicf/fCd4-Cre mice. TCR-induced
apoptosis comparably occurred in WT and Cic null double
positive (DP) thymocytes (Supplementary Fig. 8b), suggesting
that TCR-induced negative selection might not be affected by CIC
deﬁciency. Consistent with this ﬁnding, WT and Cic null CD4þ
thymocytes exhibited a comparable induction of Nur77, which
has been implicated in negative selection through its ability to
convert BCL2 into a proapoptotic molecule44,45, in response to
TCR stimulation (Supplementary Fig. 8c).
On the other hand, as observed in the Cicf/fVav1-Cre mice,
hyperglobulinemia, T-cell hyperactivation and increased popula-
tions of CD25FOXP3þ  , TH1-type and TH2-type CD4þ
T cells in spleen occurred in Cicf/fCd4-Cre mice at 12 weeks of
age (Fig. 4b, Supplementary Fig. 9). These mice also showed
several systemic autoimmune phenotypes with age, including
increased serum levels of anti-dsDNA antibody (Fig. 4c),
inﬁltration of immune cells into tissues (Fig. 4d) and glomer-
ulonephritis (Fig. 4e). Moreover, the proportions of TFH, GC TFH,
CD4þ ICOSþ T and GC B cells were signiﬁcantly higher in
Cicf/fCd4-Cre mice than in WT mice (Fig. 4f–h). The frequency
of IFNg-expressing TFH cells was increased in the spleen
of Cicf/fCd4-Cre mice (Supplementary Fig. 10a). Because
IFNg drives IgG2a class-switching in B cells during GC
reactions40,46,47, we further assessed IgG2aþ GC B cells. As
expected, the frequency and the number of IgG2aþ GC B cells
were also increased in Cicf/fCd4-Cre mice (Supplementary
Fig. 10b). Taken together, these ﬁndings demonstrate that the
spontaneous inductions of T-cell activation, GC response and
systemic autoimmunity were due to loss of CIC in T cells.
Follicular regulatory T (TFR) cells, deﬁned as CD4þ FOXP3þ
PD-1þCXCR5þ cells, are a specialized subset of regulatory
T cells that inhibit antibody production48–50. Because the
proportion of CD4þFOXP3þ T cells increased in Cic-deﬁcient
mice (Supplementary Figs 7a and 9b), we determined whether
TFR cells were increased in Cicf/fCd4-Cre mice. As with CD4þ
FOXP3PD-1þCXCR5þ TFH cells, CD4þFOXP3þPD-1þ
CXCR5þ TFR cells were also signiﬁcantly overrepresented in
the spleen of Cicf/fCd4-Cre mice compared with WT mice
(Fig. 4i). Importantly, the ratio TFH/TFR, which is a critical factor
that dictates the magnitude of antibody production50, was also
increased in the Cicf/fCd4-Cre mice (Fig. 4j), consistent with the
observation that GC B cells and serum immunoglobulin levels
were elevated in Cicf/fCd4-Cre mice (Fig. 4b,h).
Normal T-cell homeostasis in Treg-speciﬁc Cic null mice.
Although the suppressive activity toward conventional T cells and
expression proﬁles of Treg cell-associated surface molecules were
comparable between WT and Cic-deﬁcient CD4þ Treg cells
(Supplementary Fig. 7b–d), the frequency of CD4þCD25
FOXP3þ T cells was substantially increased in Cic-deﬁcient mice
(Supplementary Figs 7a and 9b). To directly address the function
of CIC in development and function of FOXP3þ Treg cells,
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we generated FOXP3þ Treg cell-speciﬁc Cic null (Cicf/fFoxp3-
YFP-Cre) mice by crossing Cicf/f mice with Foxp3-YFP-Cre
mice51. The ablation of Cic alleles in Foxp3-expressing (YFPþ )
cells did not affect formation of CD25þFOXP3þ and
CD25FOXP3þ CD4þ T cells in both thymus and spleen
(Supplementary Fig. 11a–c). The proportion of naı¨ve and
effector/memory cells for both CD4þ and CD8þ subsets, TFH,
TFR and GC B cells was also comparable between Cicþ /þFoxp3-
YFP-Cre (WT) and Cicf/fFoxp3-YFP-Cre mice (Supplementary
Fig. 11d–f). These results suggest that CIC deﬁciency in FOXP3þ
Treg cells does not cause defects in development and function of
FOXP3þ Treg cells.
Since the FOXP3þ Treg cell-speciﬁc Cic deletion did not
promote formation of CD4þCD25FOXP3þ T-cell population
in spleen (Supplementary Fig. 11c), we examined expression of
FOXP3 in conventional CD4þ T cells from WT and Cicf/fCd4-
Cre mice. Interestingly, the proportion of FOXP3-expressing
naı¨ve (CD45RBhiCD44loCD62Lhi) CD4þ T cells was markedly
increased in the spleen of Cicf/fCd4-Cre mice, compared with WT
mice (Supplementary Fig. 12a). Consistent with this result,
CD4þCD25FOXP3þ T cells in Cicf/fCd4-Cre mice were
composed of both CD44loCD62Lhi and CD44hiCD62Llo popula-
tions, while those in WT mice were mainly CD44hiCD62Llo cells
(Supplementary Fig. 12b). We also determined the origin of
CD4þCD25FOXP3þ T cells in Cicf/fCd4-Cre mice by ﬂow
cytometry analysis for expression of Helios and Neurophilin-1/
NRP1, both of which are markers for thymus-derived Treg (tTreg)
cells52–54. The frequency of HeliosNRP1 cells for both
CD25þFOXP3þ and CD25FOXP3þ T-cell subsets was
signiﬁcantly increased in the spleen of Cicf/fCd4-Cre mice
(Supplementary Fig. 12c), demonstrating that the increased
frequency of CD4þCD25FOXP3þ T cells in Cicf/fCd4-Cre
mice was due to the expansion of peripherally-induced Treg
(pTreg) cells. Taken together, our data suggest that CIC deﬁciency
induces FOXP3 expression in naı¨ve CD4þ T cells, thereby
increasing the population of CD4þCD25FOXP3þ T cells in
the periphery.
Regulation of TFH cell differentiation by the CIC–ETV5 axis.
To understand the molecular mechanism mediating the CIC
deﬁciency-induced increase in TFH cells, we set out to identify
CIC target genes in CD4þ T cells. We analysed gene expression
proﬁles in naı¨ve and anti-CD3/CD28 antibody-activated CD4þ
T cells from WT and Cicf/fCd4-Cre mice by RNA sequencing.
Among the genes signiﬁcantly upregulated (log2(fold change)
41.5; Po0.05) in Cic-deﬁcient CD4þ T cells, only Etv4 and Etv5
were upregulated irrespective of the status of T-cell activation
(Supplementary Data 1). Both Etv4 and Etv5 have been well-
characterized as CIC target genes in various tissues19,22,24,27.
qRT-PCR analysis for mRNA levels of Pea3 group genes (Etv1,
Etv4 and Etv5) (Fig. 5a) and quantitative PCR (qPCR) analysis for
Pea3 group gene promoter regions in total CIC-associated DNA
fragments (Fig. 5b) veriﬁed that Etv4 and Etv5 are direct targets of
CIC in CD4þ T cells.
We then examined the levels of Etv4 and Etv5 in CD4þ
PD-1þCXCR5þ TFH cells from WT and Cicf/fCd4-Cre mice by
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Figure 2 | Increased proportion of TFH and GC B cells in Cic
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qRT-PCR analysis. Consistent with the previous result (Fig. 5a),
levels of both genes were markedly increased in Cic-deﬁcient TFH
cells (Fig. 5c), indicating that their expression was derepressed in
TFH cells in the absence of CIC. Interestingly, however, only
ETV5 expression, but not ETV4 expression, was substantially
increased in Cic-deﬁcient TFH cells at the protein level (Fig. 5d),
suggesting that ETV4 expression is tightly controlled in TFH cells
at the posttranscriptional level. We also found that ETV5 levels
were higher in TFH cells than in non-TFH cells (Fig. 5c,e), whereas
CIC levels in the two T-cell populations were comparable
(Fig. 5e), implying that ETV5 might be critical for differentiation
or function, or both, of TFH cells. To further explore this
possibility, we performed adoptive transfer experiments using
OT-II cells, which express ovalbumin (OVA)-speciﬁc TCRs55.
Thy1.1þOT-II cells were infected with control or ETV5-
expressing retrovirus (Supplementary Fig. 13a) and adoptively
transferred to Thy1.2þ recipient mice. Immunization of the host
mice with 4-hydroxyl-3-nitrophenyl (NP)-OVA in alum resulted
in generation of a higher percentage of TFH cells (Fig. 5f),
demonstrating that ETV5 promotes TFH cell differentiation.
Consistent with this result, knockdown of ETV5 in OT-II cells by
shRNA against Etv5 (shETV5) suppressed TFH cell differentiation
(Fig. 5g). Lastly, we conducted the adoptive transfer experiment
to examine whether the increased TFH cells in Cic mutant mice
was due to derepression of ETV5. WT and Cic-deﬁcient OT-II
cells infected with control or shETV5-expressing retrovirus were
adoptively transferred to Thy1.2þ recipient mice. Seven days
after immunization with NP-OVA in alum, the donor OT-II cells
were analysed for TFH cell differentiation by ﬂow cytometry.
As expected from previous results (Figs 2a,b and 4f), TFH cell
differentiation was more prominent with Cic-deﬁcient donor
OT-II cells than with WT OT-II cells (Figs 5h and 6f). Strikingly,
such enhanced TFH cell differentiation of Cic-deﬁcient OT-II cells
was blunted when ETV5 expression was knocked-down with
shETV5 (Fig. 5h, Supplementary Fig. 13b). Altogether, these data
demonstrate that the CIC–ETV5 axis is crucial for regulation of
TFH cell differentiation.
Maf as a critical ETV5 target in TFH cell differentiation. ETV5
function in TFH cell development has not been investigated. To
comprehensively understand how the CIC–ETV5 axis regulates
differentiation of TFH cells, we sought to identify ETV5 target
genes that could be involved in this process. We initially analysed
expression proﬁles of several TFH-related genes in non-TFH and
TFH cells from WT and Cicf/fCd4-Cre mice. Bcl6, Batf, Maf, Cxcr5
and Ifng were signiﬁcantly increased, whereas Lef1 and Foxp1
were decreased in WT TFH cells compared with WT non-TFH
cells (Fig. 6a). Importantly, Batf, Maf, Icos and Ifng were
signiﬁcantly upregulated in Cic-deﬁcient TFH cells compared with
WT TFH cells; the increase was greatest in Maf, which promotes
TFH cell differentiation and GC reactions14,16 (Fig. 6a). We
conﬁrmed the overexpression of MAF in Cic-deﬁcient TFH cells at
the protein level (Fig. 6b).
We also examined which TFH-related genes are regulated by
ETV5 in CD4þ T cells. Anti-CD3/CD28 antibody-activated
CD4þ T cells were infected with control or ETV5-expressing
retrovirus and cultured in the presence of IL-6 and IL-21
(TFH-like condition)56. Among the genes tested, only Maf levels
were substantially increased by ETV5 overexpression (Fig. 6c).
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Consistent with this, it is known that Maf is a direct target
gene of ETV5 in ocular lens cells57. We conﬁrmed that
ETV5 directly bound to Maf promoter in IL-6-treated CD4þ
T cells by chromatin immunoprecipitation (ChIP)-qPCR analysis
(Supplementary Fig. 14). In contrast, in the absence of IL-6 and
IL-21, ETV5 overexpression did not signiﬁcantly increase levels of
Maf (Fig. 6d), suggesting that ETV5 might induce expression of
Maf during TFH cell development. These results were also
conﬁrmed by western blot analysis (Fig. 6e). Because IL-6 and
IL-21 can activate STAT3 pathway, we examined whether
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activation of STAT3 is required for ETV5-mediated induction
of Maf expression. Treatment with AG490 (inhibitor of
JAK2-STAT3 pathway)58 and Stattic (inhibitor for STAT3
dimerization)59 completely suppressed the induction of Maf
expression by ETV5 in CD4þ T cells incubated under TFH-like
condition (Supplementary Fig. 15a,b). However, treatment
WT cKO
ETV5
TFH cells
ETV4
β-actin
5.47
Control-RV
PD
-1
CXCR5
ETV5-RV
15.7
  10
  5
  20
PD
-1
hi
 
CX
CR
5h
i  T
FH
(%
 of
 Th
y1
.1+
 C
D4
+
)
PD
-1
hi
 
CX
CR
5h
i  T
FH
(%
 of
 Th
y1
.1+
 C
D4
+
)
PD
-1
hi
 
CX
CR
5h
i  T
FH
(%
 of
 Th
y1
.1+
 C
D4
+
)
  15
    0
*** shNC-RV shETV5-RV
3.53
  4
  2
  8
6
    0
**
10
0
8
6
4
2
R
el
at
iv
e 
fo
ld
 e
nr
ich
m
en
t
*
a b c
e f g
h
TFHNon-TFH
Spleen
ETV5
CIC-L
CIC-S
β-actin
Etv1 Etv4 Etv5
ET
V5
sh
NC
sh
ET
V5
6.56
0
1
2
3
4
R
el
at
iv
e 
fo
ld
 c
ha
ng
e
ETV4ETV5
**
Co
ntr
ol
Etv1 Etv4 Etv5
**
*
*
0
2
4
6
8
10
R
el
at
iv
e 
fo
ld
 c
ha
ng
e 12
WT CD4+ T
cKO CD4+ T
WT non-TFH
WT TFH
cKO TFH
0
2
4
6
8
10
R
el
at
iv
e 
fo
ld
 c
ha
ng
e
12
16
14
18
Etv4 Etv5
*
*
**
d
*
PD
-1
CXCR5
PD
-1
CXCR5
shNC-RV shETV5-RVshNC-RV
WT OT-II Cic cKO OT-II
7.23 15.1
  10
  5
  20
  15
    0
*** ***
WT
:sh
NC
cK
O:s
hN
C
cK
O:s
hE
TV
5
9.38
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showing CIC promoter occupancy of Etv4 and Etv5 in CD4þ Tcells. CD4þ Tcells puriﬁed from spleen of Cicf/f and Cicf/fCd4-Cre mice were used. n¼ 3 per
each genotype. (c) qRT-PCR analysis for levels of Etv4 and Etv5 in sorted CD4þPD-1CXCR5 non-TFH and CD4þPD-1þCXCR5þ TFH cells. Splenocytes
from 5 to 6 Cicf/f mice or 3 to 4 Cicf/fCd4-Cremice were pooled and subjected to cell sorting. Three independent experiments were conducted. (d) Western
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differentiation. WT:shNC, n¼ 9; cKO:shNC, n¼ 6; cKO:shETV5, n¼ 6. ***Po0.001 (two-tailed two-sample unequal variance Student t-test).
Figure 4 | Spontaneous induction of TFH cell differentiation and GC response in T-cell-speciﬁc Cic null mice. (a) Western blot analysis showing
T-cell-speciﬁc ablation of CIC expression in Cicf/fCd4-Cre mice. B220þ B and CD4þ T cells were puriﬁed from spleen of 12-week-old Cicf/f (WT) and
Cicf/fCd4-Cre (cKO) mice. (b) Levels of total IgG, IgG1, IgG2a and IgM in sera from 12-week-old Cicf/f and Cicf/fCd4-Cre mice. (c) Serum levels of
anti-dsDNA antibody in 14.5-month-old Cicf/f and Cicf/fCd4-Cremice were measured by ELISA. (b,c) The graphs show data as mean±s.e.m. and each dot in
graphs represent an individual mouse. *Po0.05 and **Po0.01 (two-tailed two-sample unequal variance Student t-test). (d) Immune cell inﬁltration in liver
and lung from 14.5-month-old Cicf/fCd4-Cre mice. Tissue sections were stained with H&E. (e) H&E-stained kidney sections showing glomerulonephritis in
14.5-month-old Cicf/fCd4-Cre mice. (d,e) Representative images from two Cicf/fCd4-Cre mice (cKO-1 and cKO-2) are shown. Scale bars, 100mm. (f–i) Flow
cytometry analyses of non-TFH, TFH and GC TFH cells (f), CD4
þ ICOSþ T cells (g), GC B cells (h) and CD4þFOXP3PD-1þCXCR5þ TFH and
CD4þFOXP3þPD-1þCXCR5þ TFR cells (i) in spleen from 12-week-old Cicf/f and Cicf/fCd4-Cre mice. All data are representative of three independent
experiments with n¼4–5 mice per group in each experiment. Numbers adjacent to outlined areas indicate per cent of each cell population among splenic
CD4þ or B220þ cells. *Po0.05, **Po0.01 and ***Po0.001 (two-tailed two-sample unequal variance Student t-test). (j) Quantiﬁcation of the ratio
TFH/TFR from the experiments as in Fig. 3i. **Po0.01 (two-tailed two-sample unequal variance Student t-test).
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with Stattic did not affect ETV5 promoter occupancy of Maf
(Supplementary Fig. 15c). These results indicate that STAT3
activity is required for ETV5-mediated induction of Maf
expression, but dispensable for ETV5 binding to Maf promoter.
Finally, we examined whether the upregulation of MAF
expression contributed to the enhanced TFH cell differentiation
in Cic-deﬁcient T cells by the adoptive transfer experiment. WT
and Cic null OT-II cells transduced with control or Maf shRNA
(shMAF)-expressing retrovirus were adoptively transferred to
Thy1.2þ recipient mice. Seven days after immunization with
NP-OVA in alum, the donor OT-II cells were analysed for TFH
cell differentiation by ﬂow cytometry. The enhanced TFH cell
differentiation of Cic-deﬁcient OT-II cells was indeed signiﬁcantly
alleviated by knockdown ofMaf (Fig. 6f, Supplementary Fig. 13b).
Taken together, these data suggest that the derepression
of Etv5 increased Maf expression in Cic-deﬁcient TFH cells,
and subsequently promoted TFH cell differentiation and GC
responses.
Discussion
In this study, we examined a previously unrecognised function of
CIC in the immune system. Our ﬁndings demonstrate that CIC is
a key transcriptional repressor that maintains peripheral immune
homeostasis and restrains TFH cell differentiation, thereby
suppressing autoimmunity (Fig. 6g). CIC deﬁciency causes
lymphoproliferative autoimmunity in mice, which is accompa-
nied by augmented T-cell responses and increased frequencies of
TFH and GC B cells in secondary lymphoid organs. Given that
excessive formation of TFH cells is often observed in patients with
autoimmune diseases5 and that autoimmunity in Roquinsan mice
is reduced when TFH cell development is suppressed either
by removing one allele of Bcl6, by deleting SAP (Sh2d1a), or by
dampening IFNg signalling40,60, spontaneous induction of the
GC response might be a primary cause of the onset of
autoimmune-like symptoms in Cic mutant mice.
The immune cell-speciﬁc Cic null mice shared many
phenotypes including hyperglobulinemia, T-cell hyperactivation,
accumulation of effector/memory cells with TH1 and TH2
phenotypes, systemic autoimmunity and increased proportions
of CD4þFOXP3þCD25 T, TFH and GC B cells with the
T-cell-speciﬁc Cic null mice, demonstrating that T-cell-intrinsic
functions of CIC are crucial for maintenance of T-cell
homeostasis and suppression of spontaneous induction of the
GC response and autoimmunity. A speciﬁc loss of CIC in B cells,
from which antigen presentation and co-stimulatory signals are
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required for differentiation and maintenance of TFH cells8, did
not promote TFH cell differentiation in mice (Supplementary
Fig. 16), accentuating the T-cell-intrinsic requirement of CIC in
regulation of TFH cell development. However, most phenotypes
were more prominent in the immune cell-speciﬁc Cic null mice
than in the T-cell-speciﬁc Cic-deﬁcient mice; this difference
implies that T-cell-extrinsic mechanisms also contributed in
part to those phenotypes. To comprehensively understand the
function of CIC in maintenance of peripheral immune tolerance,
functions of CIC in other types of immune cell, such as DCs and
B cells, need to be further determined.
Our study provided a molecular basis of how CIC deﬁciency
promotes TFH cell differentiation. We determined that ETV5 is a
critical CIC target that promotes TFH cell differentiation. Among
Pea3 group genes, Etv4 and Etv5 are major CIC target genes in
CD4þ T cells. Although mRNA levels of both genes increased
greatly in the Cic null TFH cells, only ETV5 expression increased
signiﬁcantly at the protein level, indicating that ETV4 levels
are tightly controlled in TFH cells by posttranscriptional
regulation. ETV5 expression also seems to be regulated at
the posttranscriptional level in the Cic null TFH cells, because the
increase in ETV5 expression by CIC deﬁciency was greater at the
mRNA level (B5.5-fold) than at the protein level (B3.4 fold).
One possible mechanism of posttranscriptional control of PEA3
group transcription factor levels in TFH cells is proteasomal
degradation mediated by E3 ubiquitin ligase COP1 (also known
as RFWD2). COP1-mediated degradation of PEA3 group
transcription factors is involved in regulation of prostate cancer
progression61, b-cell insulin secretion62 and lung-branching
morphogenesis63, but the function of COP1 in TFH cell
development has not been determined. Because Rfwd2 is
expressed in T lymphocytes64, one interesting follow-up would
be to examine whether COP1 regulates TFH cell differentiation
through degradation of ETV5 or other PEA3 group transcription
factors in T cells.
We identiﬁed Maf as an important downstream target gene of
the CIC–ETV5 axis in the process of TFH cell differentiation. To
identify genes that may be regulated by ETV5 during TFH cell
differentiation, we examined 14 genes that encode transcription
factors, cytokines or cell surface molecules, all of which are
critically involved in regulation of TFH cell development.
Strikingly, ETV5 overexpression induced only Maf expression
in CD4þ T cells. The ﬁnding that TFH cell differentiation of the
Cic null OT-II cells was suppressed by knockdown of Maf further
demonstrates that the CIC–ETV5 axis regulates TFH cell
differentiation via MAF. However, in the Cic-deﬁcient OT-II
cells, Maf RNAi suppressed TFH cell differentiation less efﬁciently
than did Etv5 RNAi; this comparison suggests that, in addition to
Maf, other ETV5 target genes may contribute to promotion
of TFH cell differentiation. Moreover, Cic-deﬁcient TFH cells
exhibited the enhanced expression of IFNg, which is critical for
TFH cell differentiation40, but not regulated by MAF14. This result
also implies that Maf may not be the only ETV5 target gene that
contributes to promotion of TFH cell differentiation. To improve
our understanding of how ETV5 promotes TFH cell development,
studies of the function of ETV5 in TFH cells, such as a
genome-wide identiﬁcation of ETV5 targets and their function
in TFH cells, should be conducted.
Given that ETV5 upregulated Maf expression only in the
presence of IL-6 and IL-21, which are cytokines that induce TFH
cell development56, and that Maf levels were increased in Cic null
TFH cells, but in neither naı¨ve nor anti-CD3/CD28-activated
Cic-deﬁcient CD4þ T cells (Supplementary Data 1), ETV5
might speciﬁcally regulate Maf expression during TFH cell
development. Consistent with this inference, Maf levels were
comparable between WT and Etv5 deﬁcient TH17 cells65.
However, ETV5 facilitates differentiation of TH17 cells65 and of
IL-17-producing gd effector cells66 by activating Il17 expression.
ETV5 also promotes IL-9 production in TH9 cells by binding and
recruiting histone acetyltransferases to the Il9 locus67. These
ﬁndings, together with our data, suggest that ETV5 participates in
differentiation processes of several TH subtypes by regulating a
different set of genes in each TH subset.
Our study is the ﬁrst demonstration that the CIC–ETV5 axis is
critical for regulation of TFH cell development. This axis also
contributes to cancer progression22–24; therefore, dysregulation
of this regulatory axis could contribute to pathogenesis of
both cancer and antibody-mediated autoimmune diseases. In this
regard, CIC and ETV5 themselves or their target genes
that commonly mediate pathogenesis of both diseases could be
evaluated as molecular targets for treatment of both autoimmune
diseases and cancers.
Methods
Mice. All mice were maintained on a C57BL/6 background. Vav1-Cre (ref. 68),
Cd4-Cre (ref. 69), Foxp3-YFP-Cre (ref. 51), Cd19-Cre (ref. 70) and OT-II (ref. 55)
mice have been described previously. The mouse with a loxP-ﬂanked Cic allele was
generated by mating Cictm1a(KOMP)Wtsi to Actin-FLP mice (Stock No: 003800). The
Cictm1a(KOMP)Wtsi allele had been obtained as ES cells (Clone No. EPD0285_3_F07)
from EUCOMM and injected into C57BL/6 blastocysts. Animals were maintained
in a speciﬁc pathogen-free animal facility under standard 12 h light/12 h dark cycle.
Mice were fed standard rodent chow and water ad libitum. Three-to-thirteen
mice that were used in individual experiments were assigned randomly to the
experimental groups. Male and female mice were also randomly assigned to the
experimental groups. Blinding was not possible in most animal experiments. All
procedures were approved by the Pohang University of Science and Technology
Institutional Animal Care and Use Committee.
Enzyme-linked immunosorbent assay. Ninety six-well ELISA plates were
pre-coated with 2 mgml 1 anti-mouse Ig (1010-01, Southern Biotechnology) at
4 C overnight. On the next day, the plates were washed with washing buffer
(phosphate-buffered saline (PBS) with 0.05% Tween 20) and blocked with blocking
buffer (washing buffer with 2% bovine serum albumin (BSA)) for 1–2 h at room
temperature (RT); then 50 ml of diluted serum and standards were added and
incubated for 2 h at RT. The plates were washed and incubated for 1 h at RT with
secondary antibodies conjugated with horseradish peroxidase. For total IgG, goat
anti-mouse IgG (Hþ L) (pooled antisera from goats hyperimmunized with mouse
IgG, 1:3,000 diluted, 1031-05) was used; for IgG1, goat anti-mouse IgG1 (pooled
antisera from goats hyperimmunized with mouse IgG1, 1:3,000 diluted, 1070-05)
was used; for IgG2a, goat anti-mouse IgG2a (pooled antisera from goats hyper-
immunized with mouse IgG2a paraproteins, 1:1,000 diluted, 1080-05) was used;
and for IgM, goat anti-mouse IgM (pooled antisera from goats hyperimmunized
with mouse IgM, 1:2,000 diluted, 1020-05) was used. The plates were washed at
least ﬁve times, then 50ml of TMB substrate (SurModics, TMBM-1000-01) was
added and incubated for 20min in the dark. Finally, 50 ml of stop solution (1M
H2SO4) was added and the plate was read at 450 nm. The serum concentration
was calculated according to the standard curve generated. Serum anti-dsDNA
concentration was measured using mouse anti-dsDNA ELISA Kit (Shibayagi,
AKRDD-061) according to the manufacturer’s instruction. For IL-2 ELISA, naı¨ve
CD4þ T cells were activated with plate-bound anti-CD3 (1.0 mgml 1, 145-2C11,
BD) in the presence or absence of plate-bound anti-CD28 (2.0 mgml 1, 37.51,
BD), then cell supernatants were collected 48 and 72 h after stimulation. Brieﬂy,
plates pre-coated with 2 mgml 1 anti-IL-2 (14-7022, eBioscience) were washed
and blocked as described above, then 50 ml of diluted samples and standards were
added and incubated for 2 h at RT. The plates were washed, then incubated
sequentially with biotin-conjugated anti-IL-2 (13-7021) for 1.5 h, avidin-HRP
(18-4100) for 30min, TMB substrate for 15min, and 1M H2SO4 as a stop solution.
Tissue histology. Liver, lung and kidney tissues obtained from 12-month-old
Cicf/f and Cicf/fVav1-Cremice or 14.5-month-old Cicf/f and Cicf/fCd4-Cre mice were
ﬁxed in 10% formalin, then embedded in parafﬁn before sectioning. The tissues
were cut into 5-mm sections (Leica RM2245), then sections were deparafﬁnized and
dehydrated by using xylene, 100% ethanol and 95% ethanol sequentially. They were
washed in distilled water, then stained with haematoxylin (Sigma, HHS32) and
eosin (Sigma, HT110132). After H&E staining,  200 images of specimens were
obtained using an Olympus CX31 light microscope.
Immunoﬂuorescence staining of IgG deposition. Kidney tissues from
12-month-old Cicf/f and Cicf/fVav1-Cre mice were snap-frozen in OCT medium
(Sakura Finetek, 4583), then cut into 10-mm sections (Leica CM3050S). The kidney
sections were air-dried for 24 h, then washed in PBS (pH 7.4) to remove ﬁxation
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compound. Diluted anti-mouse CD16/CD32 antibodies (eBioscience, 14-0161)
were treated for Fc blocking and incubated for 30min at RT. After washing, the
kidney sections were stained with anti-IgG antibody conjugated to ﬂuorescein
isothiocyanate (FITC) (1:500 diluted, Sigma, F0257) and 40 ,6-diamidino-2-
phenylindole to reveal the IgG complexes and the nuclei, respectively. The
specimens were washed in PBS, then covered in mounting medium (Dako, C0563),
and  400 images of specimens were obtained using an Olympus IX82-ZDC2
ﬂuorescence microscope.
Plasmids and retrovirus production. The amino-terminal FLAG-tagged coding
sequence (CDS) of mouse Etv5 was ampliﬁed by PCR, initially cloned into T-blunt
vector (SolGent), and then veriﬁed by sequencing. A conﬁrmed Etv5 CDS fragment
digested by XhoI/HpaI was sub-cloned into MigR1 retroviral vector (MigR1-ETV5-
GFP). The shRNA expression vectors for knockdown of mouse Etv5 and Maf
were generated using MSCV-LTRmiR30-PIG (LMP) vector (Open Biosystems)
according to the manufacturer’s instruction. The target sequences were as follows.
For shETV5: 50-ACCCGAGAGACTGGAAGGCAAA-30 and for shMAF: 50-AAG
ATATAACCTGCAAGCATAT-30 .
Viruses were generated by transient co-transfection of Platinum-E (Plat-E)
retroviral packaging cell line (Cell Biolabs) with the cloned retroviral vectors and
pCL-Eco helper plasmid (Imgenex). Brieﬂy, 0.5–0.8 106 plat-E cells were plated
in 6-well plates. On the next day, the cells were transfected with 1.2 mg of retroviral
vector and 0.8 mg of pCL-Eco using FuGENE HD transfection reagent (E2311,
Promega). Retrovirus-containing supernatants were collected 48 h later and frozen
at  80 C.
Flow cytometry and cell sorting. Single-cell suspensions of spleens and thymuses
were prepared and surface-stained in FACS buffer (PBSþ 1.5% fetal bovine serum
(FBS)) with monoclonal antibodies. The following antibodies were obtained from
eBioscience, BD PharMingen or BioLegend: anti-CD4 (1:100 diluted, GK1.5),
anti-CD8 (1:100 diluted, 53-6.7), anti-CD3 (1:100 diluted, 17A2), anti-CD11b
(1:100 diluted, M1/70), anti-CD11c (1:100 diluted, N418), anti-MHCII (1:100
diluted, AF6-120.1), anti-F4/80 (1:100 diluted, BM8), anti-CD44 (1:100 diluted,
IM7), anti-CD62L (1:100 diluted, MEL-14), anti-CD25 (1:50 diluted, PC61),
anti-PD-1 (1:50 diluted, J43), anti-GITR (1:100 diluted, DTA-1), anti-OX40 (1:100
diluted, OX-86), anti-ICOS (1:100 diluted, 7E.17G9), anti-B220 (1:200 diluted,
RA3-6B2), anti-IgM (1:100 diluted, II/41), anti-CD43 (1:100 diluted, R2/60),
anti-GL-7 (1:250 diluted, GL7), biotinylated anti-mouse FAS (1:200 diluted, Jo2),
anti-CD40 (1:100 diluted, 1C10), anti-CD80 (1:100 diluted, 16-10A1), anti-CD86
(1:100 diluted, GL1), anti-ICOSL (1:100 diluted, HK5.3), anti-PDCA-1 (1:100
diluted, eBio927), anti-CCR4 (1:100 diluted, 2G12), anti-CCR6 (1:100 diluted,
140706), anti-CXCR3 (1:150 diluted, CXCR3-173), anti-CTLA-4 (1:100 diluted,
UC10-4B9), anti-CD103 (1:100 diluted, 2E7), anti-GARP (1:100 diluted, YGIC86),
anti-IgG2a (1:100 diluted, m2a-15F8), anti-CD304 (Neuropilin-1; 1:50 diluted,
3E12) and APC-conjugated streptavidin (1:100 diluted, eBioscience). For CXCR5
staining, tertiary staining was used11. Brieﬂy, the cells were sequentially incubated
with following reagents: rat anti-CXCR5 (1:100 diluted, 2G8) for 1 h, biotinylated
anti-rat IgG (1:400 diluted, eBioscience) for 30min, and then APC- or PerCP-
Cy5.5-labelled streptavidin (1:100 diluted, eBioscience) with other surface
antibodies. For intracellular staining, cells were ﬁxed and permeabilized with
‘Foxp3 staining buffer set’ (00-5523, eBioscience) following the manufacturer’s
protocol, then stained with anti-Foxp3 (1:75 diluted, MF23, BD), anti-BCL6
(1:50 diluted, 7D1), anti-T-bet (1:100 diluted, 4B10), anti-GATA3 (1:100 diluted,
TWAJ), anti-RORgt (1:100 diluted, B2D), anti-Nur77 (1:100 diluted, 12.14) and
anti-HELIOS (1:100 diluted, 22F6). For cytokine staining, total splenocytes were
stimulated with PMA and ionomycin in the presence of Golgi-stop (554724, BD)
and Golgi-plug (555029, BD) for 5 h, and then the intracellular staining of
cytokines was performed using antibodies for IFNg (1:100 diluted, XMG1.2), IL-2
(1:100 diluted, JES6-5H4), IL-17A (1:100 diluted, TC11-18H10), TNF (1:200
diluted, MP6-XT22), IL-21 (1:100 diluted, mhalx21), IL-4 (1:50 diluted, 11B11),
IL-9 (1:100 diluted, RM9A4), IL-13 (1:100 diluted, eBio13A) and IL-22
(1:100 diluted, Poly5164). The stained cell samples were analysed using either a
CantoII ﬂow cytometer (BD Biosciences) or a LSRFortessa ﬂow cytometer
(BD Biosciences). Data were analysed by FlowJo software (Tree Star). MoFlo-XDP
(Beckman Coulter) was used for cell sorting. The sorted populations were498.5%
pure. In FACS plots, isotype controls for each of antibodies were used
for separating negative and positive populations and all gates were based
on this method. All FACS sorting/gating strategies are described in Supplementary
Fig. 17.
In vitro T-cell proliferation assay. Naı¨ve CD4þ T cells were puriﬁed to 495%
purity from pooled spleens and lymph nodes of Cicf/f and Cicf/fVav1-Cre mice by
using a CD4þ negative selection method (Stem Cell Technologies) for CD4þ
CD25CD44loCD62Lhi cells. The cells were labelled with 5 mM Cell Trace Violet
(CTV, Invitrogen, C34557) in pre-warmed PBS. Labelling was performed by
incubating in a 37 C incubator for 20min and stopped by adding ﬁve times the
original staining volume of culture medium (containing Z1% protein). The cells
were incubated for at least 10min to allow the CTV reagent to undergo acetate
hydrolysis. The cells were stimulated with plate-bound anti-CD3 (1.0 mgml 1,
145-2C11, BioXcell) and anti-CD28 (2.0 mgml 1, 37.51, BioXcell), then collected
72 h after stimulation. The samples were analysed using the LSRFortessa ﬂow
cytometer. Data were analysed using FlowJo software (Tree Star).
In vitro T-cell differentiation assay. Naı¨ve CD4þ T cells (CD4þCD25
CD44loCD62Lhi) were stimulated with plate-bound anti-CD3 and anti-CD28 in
medium supplemented as follows: for TH0 differentiation, anti-IL-4 (10mgml 1)
and anti-IFNg (10 mgml 1); for TH1 differentiation, IL-12 (10 ngml 1) and
anti-IL-4 (10 mgml 1); for TH2 differentiation, IL-4 (10 ngml 1) and anti-IFNg
(10 mgml 1); for TH17 differentiation, IL-1b (20 ngml 1), IL-6 (20 ngml 1),
TGF-b (2 ngml 1), anti-IFNg (10 mgml 1) and anti-IL-4 (10 mgml 1). The
samples were analysed using the LSRFortessa ﬂow cytometer, and data were
analysed using FlowJo software.
In vitro Treg cell suppression assay. CD4þCD25 CD44lo T cells were prepared
from CD45.1 C57BL/6 mice. The cells were labelled with CTV and used as
responder cells (Tresp). CD4þCD25þ Treg cells were isolated from Cicf/f and
Cicf/fCd4-Cre mice by the MoFlo-XDP (Beckman Coulter). Tresp cells were mixed
with an equal number of irradiated splenocytes (3000 Rad) from Rag1 / mice
and different numbers of CD4þCD25þ Treg cells and incubated in round bottom
96-well tissue culture plates with anti-CD3 (1 mgml 1). Seventy-two hours later,
CD45.1þ CD4þ T cells were gated and proliferation was analysed based on CTV
dilution. For detection of IL-2 secretion, CD4þCD25þ Treg cells from Cicf/f and
Cicf/fCd4-Cre mice were used at a ﬁxed concentration of 1 105 cells per well
and co-cultured with CD4þCD25 Tresp cells in 96-well plates. The cells were
stimulated with plate-bound anti-CD3 (1 mgml 1) and anti-CD28 (1 mgml 1),
then supernatants were collected 72 h after stimulation. The samples were subjected
to ELISA for IL-2 concentration.
Thymic negative selection assay. In vitro thymic negative selection assay was
performed as described previously45. Brieﬂy, DP thymocytes were prepared from
Cicf/f and Cicf/fCd4-Cre mice using the MoFlo-XDP and stimulated with anti-CD3
(20 mgml 1) and anti-CD28 (50mgml 1) for 24 h to evaluate TCR-induced
apoptosis. Cell death was assessed by staining for Annexin V according to the
manufacturer’s protocol (BD, 556419). To investigate the induction of Nur77
expression after TCR cross-linking, thymocytes from Cicf/f and Cicf/fCd4-Cre mice
were stimulated with anti-CD3 (5mgml 1) and anti-CD28 (10 mgml 1) for 6 h.
The samples were analysed using the LSRFortessa ﬂow cytometer, and data were
analysed using FlowJo software.
Western blot analysis. Single-cell suspensions of spleen, lymph nodes and
thymus from Cicf/f and Cicf/fVav1-Cre mice were used as total immune cells in
lymphoid organs. Naı¨ve CD4þ T cells were activated by anti-CD3 and anti-CD28
and collected on days 0 (unstimulated), 1, 2 and 3. B220þ B and CD4þ T cells
from Cicf/f and Cicf/fCd4-Cre mice were prepared using MACS (130-049-501 and
130-104-454, Miltenyi Biotec) according to the manufacturer’s protocol. Naı¨ve
CD4þ T, effector/memory CD4þ T, TFH and non-TFH cells were puriﬁed from
total CD4þ T cells by FACS sorting using the MoFlo-XDP. Splenic CD19þ B and
CD3þ T cells were prepared from Cicf/f and Cicf/fCd19-Cre mice by FACS sorting
using the MoFlo-XDP. Total lysates from 0.2 to 1.0 106 cells of each cell
population were separated by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS–PAGE). The primary antibodies used are as follows. anti-CIC (1:500
diluted, homemade)28, anti-ETV4 (1:1,000 diluted, 10684-1-AP, ProteinTech),
anti-ERM/ETV5 (1:1,000 diluted, ab102010, Abcam), anti-MAF (1:750 diluted,
sc-7866, Santa Cruz Biotechnology), anti-b-actin (1:2,000 diluted, sc-47778,
Santa Cruz Biotechnology) and anti-GAPDH (1:2,000 diluted, sc-32233, Santa
Cruz Biotechnology). Raw western blot images are presented in Supplementary
Figs 18 and 19.
Retroviral transduction and cell transfers. OT-II Thy1.1 CD4þ T cells were
puriﬁed from whole splenocytes by negative selection using EasySep (StemCell),
then re-suspended in T-cell medium (RPMI-1640þ 10% FBS, supplemented with
2.05mM L-Glutamine, 100Uml 1 Penicillin/Streptomycin and 55mM BME). The
puriﬁed OT-II T cells were stimulated in 24-well plates pre-coated with 2 mgml 1
anti-CD3 (145-2C11, BD) and anti-CD28 (37.51, BD) in the presence of rmIL-2
(50Uml 1). The OT-II T cells were transduced with control retrovirus
(MigR1-GFP) or ETV5-expressing retrovirus (MigR1-ETV5-GFP) at 24 and 48 h
after in vitro stimulation. After a total of 72 h stimulation, the cells were transferred
into new six-well plates with rmIL-2 for 24 h, and then transferred again into new
six-well plates in the presence of rmIL-7 for 24 h prior to cell sorting. For shRNA
experiments, after in vitro stimulation and double transduction with shNC,
shETV5 or shMAF expressing retrovirus for 72 h, the cells were transferred into
six-well plates with rmIL-2 for 12 h and then transferred into new six-well plates
with rmIL-7 for 12 h.
For adoptive transfer experiments, 0.2–0.5 106 OT-II T cells infected with
retroviruses were transferred into C57BL/6 Thy1.2 recipient mice by tail-vein
injection. Three days later, mice were immunized intraperitoneally with 200 mg of
NP-OVA (9006-59-1, Sigma) in 200ml of alum. Seven or eight days after
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immunization, the donor cells were analysed for TFH differentiation by ﬂow
cytometry.
Cell culture. Naı¨ve (CD4þCD25CD44loCD62Lhi) CD4þ T cells were isolated
by negative selection using EasySep (StemCell), then activated with plate-bound
anti-CD3 (145-2C11, BD) and anti-CD28 (37.51, BD) under neutral (anti-IFNg,
anti-IL-4, anti-TGFb) or TFH-like (anti-IFNg, anti-IL-4, anti-TGFb, rmIL-6,
rmIL-21) condition. The cells were transduced with retrovirus (MigR-GFP or
MigR-ETV5-GFP) at 24 h and at 36 h after in vitro stimulation. Two days after
culture, the cells were rested for 24 h in the presence of rmIL-7, then re-stimulated
with pre-coated anti-CD3 for 2 h for RNA samples and for 12 h for protein
samples.
For STAT3 inhibitor treatment experiments, naı¨ve CD4þ T cells were
polarized under TFH-like condition as described above. The cells were transduced
with retrovirus (MigR1-GFP or MigR1-ETV5-GFP) at 24 h after in vitro
stimulation, then treated with AG490 (Tokyo Chemical, 50 mM) for 16 h or Stattic
(Santa Cruz Biotechnology, 20 mM) for 12 h. Two days after culture, the cells were
rested for 24 h. The cells were collected for RNA samples.
ChIP and qPCR. Chromatin immunoprecipitation was performed as previously
described28. Chromatin from 5 106 CD4þ T cells were crosslinked in 1.5%
formaldehyde for 12min with constant shaking, quenched cross-linking by adding
1.5M glycine for 10min, and then rinsed with cold PBS twice. After centrifugation
for 5min, the pellet was resuspended in Buffer A (100mM Tris pH 9.4,
1 protease inhibitor cocktail (11836170001, Roche)), Buffer 1 (10mM HEPES,
10mM EDTA, 0.5mM EGTA, 0.25% Triton-X, 1 protease inhibitor cocktail),
and Buffer 2 (10mM HEPES, 0.2M NaCl, 1mM EDTA, 0.5mM EGTA, 1
protease inhibitor cocktail), successively. T-cell lysate was resuspended in 200 ml of
nuclei lysis buffer (5mM Tris pH 8.1, 10mM EDTA, 1% SDS, 1 protease
inhibitor cocktail) and sonicated. After microcentrifugation, the supernatant was
pre-cleared with protein G agarose (16-266, Millipore) in dilution buffer (16.7mM
Tris pH 8.1, 167mM NaCl, 1.2mM EDTA, 0.01% SDS, 1.1% Triton-X, 1
protease inhibitor) for 1–2 h. Six micrograms of anti-CIC antibody (homemade)28
were added to chromatin samples and incubated overnight at 4 C. The chromatin
and antibody mixtures were further incubated with protein G agarose for 2–4 h at
4 C. After washing, bound chromatins were eluted twice by elution buffer (0.5%
SDS and 0.1M NaHCO3) and reverse-crosslinked with 200mM NaCl for at least
4 h at 65 C. Proteins were digested by proteinase K and DNA was puriﬁed by
AccuPrep Gel Puriﬁcation Kit (K-3034, Bioneer). qPCR was performed to quantify
the relative enrichment of promoter regions of Pea3 group genes in the
immunoprecipitated DNA fragments.
For ETV5 ChIP experiment, CD4þ T cells were activated with plate bound
anti-CD3 (145-2C11, BD) and anti-CD28 (37.51, BD) in the presence of rmIL-6.
Sixteen hours after in vitro stimulation, 1 107 cells and 2 mg of anti-ETV5
antibody (sc-22807, Santa Cruz Biotechnology) were used for each ChIP
experiment. To inhibit STAT3 activity, CD4þ T cells were activated with anti-
CD3/CD28 in the presence of rmIL-6 for 12 h, and then Stattic (20 mM) was treated
for 12 h. The primer sequences used are listed in Supplementary Data 2.
qRT-PCR. Total RNA was extracted using Trizol reagent (301-001, GeneAll),
then 1–2 mg of the total RNA was subjected to cDNA synthesis using a GoScript
Reverse Transcription System (A5000, Promega). Each gene expression level was
normalized to Hprt levels and presented as relative to WT. The primers used in
qRT-PCR analyses are listed in Supplementary Data 3.
RNA sequencing and data analysis. Spleens were dissected from 10-week-old
Cicf/f and Cicf/fCd4-Cre mice. CD4þ T cells were pre-enriched using EasySep
(19860 and 18001, StemCell), then further sorted on the basis of surface markers of
naı¨ve CD4þ T cells (CD4þCD44loCD62Lhi). Sorted naı¨ve CD4þ T cells were
activated in 24-well plates pre-coated with 2 mgml 1 anti-CD3 (145-2C11, BD)
and anti-CD28 (37.51, BD) for 3d. Total RNA was extracted from naı¨ve and
activated CD4þ T cells using ReliaPrep RNA Cell Miniprep Kit (Z6011, Promega).
The library for mRNA sequencing was generated using a Illumnia TruSeq
Preparation Kit (RS-122-2001) and sequenced on a NextSeq 500 sequencer
(Illumnia). Tophat (v 2.0.10) was used to map sequencing reads to the mouse
reference genome (mm9 RefSeq). Assembly of transcripts and identiﬁcation of
differentially expressed genes (DEGs, Fold change (log2)41.5; Po0.05) were
conducted by Cufﬂinks (v 2.1.1).
Statistical analysis. For statistical analysis, all experiments were performed more
than three times independently. Statistical analyses were performed using the
Student t-test (two-tailed, two-sample unequal variance). Po0.05 was considered
signiﬁcant. In bar graphs, bars indicate means and error bars indicate SEM. In
box-and-whisker plots, boxes represent median with upper and lower quantiles and
whiskers represent values of maximum and minimum.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within the article and its Supplementary Information Files,
or from the corresponding authors on reasonable request. The RNA-seq data
were deposited in the Gene Expression Omnibus (NCBI) data repository under
accession number GSE84125.
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